Literature DB >> 15737650

Reverse engineering the L-type Ca2+ channel alpha1c subunit in adult cardiac myocytes using novel adenoviral vectors.

Anand N Ganesan1, Brian O'Rourke, Christoph Maack, Henry Colecraft, Agnieszka Sidor, David C Johns.   

Abstract

The alpha(1c) subunit of the cardiac L-type Ca(2+) channel, which contains the channel pore, voltage- and Ca(2+)-dependent gating structures, and drug binding sites, has been well studied in heterologous expression systems, but many aspects of L-type Ca(2+) channel behavior in intact cardiomyocytes remain poorly characterized. Here, we develop adenoviral constructs with E1, E3 and fiber gene deletions, to allow incorporation of full-length alpha(1c) gene cassettes into the adenovirus backbone. Wild-type (alpha(1c-wt)) and mutant (alpha(1c-D-)) Ca(2+) channel adenoviruses were constructed. The alpha(1c-D-) contained four point substitutions at amino acid residues known to be critical for dihydropyridine binding. Both alpha(1c-wt) and alpha(1c-D-) expressed robustly in A549 cells (peak L-type Ca(2+) current (I(CaL)) at 0 mV: alpha(1c-wt) -9.94+/-1.00pA/pF, n=9; alpha(1c-D-) -10.30pA/pF, n=12). I(CaL) carried by alpha(1c-D-) was markedly less sensitive to nitrendipine (IC(50) 17.1 microM) than alpha(1c-wt) (IC(50) 88 nM); a feature exploited to discriminate between engineered and native currents in transduced guinea-pig myocytes. 10 microM nitrendipine blocked only 51+/-5% (n=9) of I(CaL) in alpha(1c-D-)-expressing myocytes, in comparison to 86+/-8% (n=9) of I(CaL) in control myocytes. Moreover, in 20 microM nitrendipine, calcium transients could still be evoked in alpha(1c-D-)-transduced cells, but were largely blocked in control myocytes, indicating that the engineered channels were coupled to sarcoplasmic reticular Ca(2+) release. These alpha(1c) adenoviruses provide an unprecedented tool for structure-function studies of cardiac excitation-contraction coupling and L-type Ca(2+) channel regulation in the native myocyte background.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737650      PMCID: PMC2751644          DOI: 10.1016/j.bbrc.2005.02.015

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  Functional regulation of L-type calcium channels via protein kinase A-mediated phosphorylation of the beta(2) subunit.

Authors:  M Bünemann; B L Gerhardstein; T Gao; M M Hosey
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

2.  Factors that control sarcoplasmic reticulum calcium release in intact ventricular myocytes.

Authors:  D M Bers; L Li; H Satoh; E McCall
Journal:  Ann N Y Acad Sci       Date:  1998-09-16       Impact factor: 5.691

3.  A cardiac dihydropyridine receptor II-III loop peptide inhibits resting Ca(2+) sparks in ferret ventricular myocytes.

Authors:  Y Li; D M Bers
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

4.  Novel functional properties of Ca(2+) channel beta subunits revealed by their expression in adult rat heart cells.

Authors:  Henry M Colecraft; Badr Alseikhan; Shoji X Takahashi; Dipayan Chaudhuri; Scott Mittman; Vasan Yegnasubramanian; Rebecca S Alvania; David C Johns; Eduardo Marbán; David T Yue
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

5.  Distinctive modulatory effects of five human auxiliary beta2 subunit splice variants on L-type calcium channel gating.

Authors:  Shoji X Takahashi; Scott Mittman; Henry M Colecraft
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

6.  Cytoprotective role of Ca2+- activated K+ channels in the cardiac inner mitochondrial membrane.

Authors:  Wenhong Xu; Yongge Liu; Sheng Wang; Todd McDonald; Jennifer E Van Eyk; Agnieszka Sidor; Brian O'Rourke
Journal:  Science       Date:  2002-11-01       Impact factor: 47.728

Review 7.  Progress and problems with the use of viral vectors for gene therapy.

Authors:  Clare E Thomas; Anja Ehrhardt; Mark A Kay
Journal:  Nat Rev Genet       Date:  2003-05       Impact factor: 53.242

8.  Evidence for the existence of a cardiac specific isoform of the alpha 1 subunit of the voltage dependent calcium channel.

Authors:  D F Slish; D B Engle; G Varadi; I Lotan; D Singer; N Dascal; A Schwartz
Journal:  FEBS Lett       Date:  1989-07-03       Impact factor: 4.124

9.  Skeletal and cardiac ryanodine receptors bind to the Ca(2+)-sensor region of dihydropyridine receptor alpha(1C) subunit.

Authors:  J Mouton; M Ronjat; I Jona; M Villaz; A Feltz; Y Maulet
Journal:  FEBS Lett       Date:  2001-09-21       Impact factor: 4.124

10.  Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions.

Authors:  C Y Chiu; E Wu; S L Brown; D J Von Seggern; G R Nemerow; P L Stewart
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

View more
  4 in total

1.  Beta-adrenergic stimulation of L-type Ca2+ channels in cardiac myocytes requires the distal carboxyl terminus of alpha1C but not serine 1928.

Authors:  Anand N Ganesan; Christoph Maack; David C Johns; Agnieszka Sidor; Brian O'Rourke
Journal:  Circ Res       Date:  2006-01-05       Impact factor: 17.367

2.  Manipulating L-type calcium channels in cardiomyocytes using split-intein protein transsplicing.

Authors:  Prakash Subramanyam; Donald D Chang; Kun Fang; Wenjun Xie; Andrew R Marks; Henry M Colecraft
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

3.  Functional expression of transgenic 1sDHPR channels in adult mammalian skeletal muscle fibres.

Authors:  Marino DiFranco; Philip Tran; Marbella Quiñonez; Julio L Vergara
Journal:  J Physiol       Date:  2011-01-24       Impact factor: 5.182

4.  The PDZ motif of the α1C subunit is not required for surface trafficking and adrenergic modulation of CaV1.2 channel in the heart.

Authors:  Lin Yang; Alexander Katchman; Richard L Weinberg; Jeffrey Abrams; Tahmina Samad; Elaine Wan; Geoffrey S Pitt; Steven O Marx
Journal:  J Biol Chem       Date:  2014-12-11       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.